The modern CBD phenomenon Several factors have
Post# of 85521
(Total Views: 491)
Posted On: 08/31/2019 3:34:08 PM
The modern CBD phenomenon
Several factors have aligned in favor of the present-day cannabis surge. It comes at a time of widespread disaffection with a broken, overpriced health care system that strives to sell addicting drugs instead of age-old herbal medicines.
Although the mainstream embrace of CBD has all the signs of a fad, it’s also driven by a hunger for alternatives to harsh pharmaceuticals, a sincere desire for medicine more in synch with our body’s natural processes.
For some struggling with serious illness, cannabis oil is a last-ditch Hail Mary pass. For many others, it is a tonic for coping with endemic despair in a country where substance abuse, depression, and suicide rates are at all-time highs.
Legal ambiguities aside, public enthusiasm for CBD and cannabis is driving a multibillion-dollar “green rush.” This green rush is what UNVC and Doctor Dalton hopes to capitalize on.
Over 64 million Americans reportedly use a CBD product, and
many for conditions that were unresponsive to conventional therapies.
Although the FDA has the authority to crack down on non-pharmaceutical CBD products, so far it has used this authority only sparingly. The limited FDA enforcement policy is in part a reflection of the growing economic and political clout of the cannabis sector. The FDA can’t scale with the magnitude of this cultural groundswell. It can’t put the CBD genie back in the bottle even if it wanted to. So the time is near for all of us, and one can’t help but wonder what the future might bring. Let’s hope the parts to this puzzle are in place, and the springboard is about to propel us to heights unseen.
Kgem
Several factors have aligned in favor of the present-day cannabis surge. It comes at a time of widespread disaffection with a broken, overpriced health care system that strives to sell addicting drugs instead of age-old herbal medicines.
Although the mainstream embrace of CBD has all the signs of a fad, it’s also driven by a hunger for alternatives to harsh pharmaceuticals, a sincere desire for medicine more in synch with our body’s natural processes.
For some struggling with serious illness, cannabis oil is a last-ditch Hail Mary pass. For many others, it is a tonic for coping with endemic despair in a country where substance abuse, depression, and suicide rates are at all-time highs.
Legal ambiguities aside, public enthusiasm for CBD and cannabis is driving a multibillion-dollar “green rush.” This green rush is what UNVC and Doctor Dalton hopes to capitalize on.
Over 64 million Americans reportedly use a CBD product, and
many for conditions that were unresponsive to conventional therapies.
Although the FDA has the authority to crack down on non-pharmaceutical CBD products, so far it has used this authority only sparingly. The limited FDA enforcement policy is in part a reflection of the growing economic and political clout of the cannabis sector. The FDA can’t scale with the magnitude of this cultural groundswell. It can’t put the CBD genie back in the bottle even if it wanted to. So the time is near for all of us, and one can’t help but wonder what the future might bring. Let’s hope the parts to this puzzle are in place, and the springboard is about to propel us to heights unseen.
Kgem
(4)
(0)Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼